Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1447965

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1447965

Drug Delivery Devices Market - Global Drug Delivery Devices Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2033

PUBLISHED:
PAGES:
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

The global drug delivery devices market is anticipated to witness substantial expansion over the coming decade, with projections indicating a surge from approximately US$35.4 billion in 2023 to a staggering US$90.2 billion by the end of 2033. This growth trajectory, representing a robust Compound Annual Growth Rate (CAGR) of 6.2% between 2023 and 2033, underscores significant opportunities and challenges within the industry.

Smart Drug Delivery Devices: Empowering Patients, Revolutionizing Healthcare

The market is experiencing a paradigm shift fueled by the rising adoption of smart drug delivery devices. These innovative technologies cater to patients' desire for enhanced control and convenience in healthcare management. With features such as automated dosing, reminders, and data tracking, smart devices not only improve medication adherence but also enable remote patient monitoring, particularly in the realm of telemedicine.

Navigating Regulatory Challenges: Balancing Innovation with Compliance

While the market showcases immense potential, regulatory hurdles pose significant barriers to entry and innovation. Lengthy approval processes by regulatory bodies like the US FDA and EMA delay market entry and deter companies from pursuing novel technologies. Addressing these challenges is crucial for fostering innovation and ensuring the timely introduction of patient-friendly and cost-efficient drug delivery devices.

Painless Alternatives Gain Momentum: Needle-Free Anaesthesia and Injectors on the Rise

A notable trend in the market is the increasing demand for painless and needle-free drug delivery solutions, particularly among pediatric and geriatric populations. Needle-free anaesthesia and injectors offer safe and effective alternatives to traditional methods, driving significant demand and reshaping the landscape of pain management in healthcare.

US FDA's Crucial Role: Safeguarding Safety and Effectiveness

The regulatory landscape, spearheaded by agencies like the US FDA, plays a pivotal role in ensuring the safety and effectiveness of medical devices. Compliance with stringent regulatory standards is essential for the development, approval, and market success of drug delivery devices, underscoring the importance of adherence to regulatory controls.

Insulin Pens Dominate: Convenience and Precision Enhance Patient Adherence

Insulin pens emerge as frontrunners in the market, offering unparalleled convenience, ease of use, and precise dosing. Their user-friendly design and reduced pain facilitate better patient adherence, ultimately leading to improved glycemic control and enhanced patient outcomes.

Disposable Devices Revolutionize Self-Administration: Convenience Meets Safety

Disposable drug delivery devices, characterized by convenience and safety, are witnessing increased adoption, particularly in self-administration scenarios. These devices eliminate the need for cleaning, minimizing the potential for medication errors and enhancing patient safety and treatment effectiveness.

Subcutaneous Delivery Surges: Catering to the Rise in Biologics and Patient Preferences

The preference for subcutaneous drug delivery is on the rise, driven by the increasing utilization of biologics and the growing demand for self-administration options. Subcutaneous delivery offers a less invasive and comfortable alternative, promoting patient compliance and driving the need for user-friendly delivery devices.

North America Leads Innovation: Technological Advancements and Stringent Regulations

North America emerges as a frontrunner in the global market, fueled by the region's focus on technological advancements, robust healthcare infrastructure, and adherence to stringent regulatory standards. Continuous innovations and investments in drug delivery technologies contribute to the region's prominence in the global landscape.

Competitive Analysis:

Manufacturers are constantly improving drug delivery devices, focusing on efficiency, safety, and patient convenience. They invest in innovative technologies like smart devices and biocompatible materials. Collaborations with pharmaceutical companies, research institutions, and technology firms accelerate product development and expand market reach.

Leaders in The Global Drug Delivery Devices Market including:

  • Eli Lilly and Company
  • Becton Dickinson And Co.
  • Novo Nordisk
  • Sanofi
  • Johnson & Johnson
  • Roche
  • Pfizer
  • AbbVie
  • Mylan N.V. (Viatris)
  • Insulet corporation
  • Medtronic Plc

Global Drug Delivery Devices Market Is Segmented as Below:

By Product:

  • Self-Injector
    • Single Chamber Self Injector
    • Dual Chamber Self Injector
  • Needle Free Injectors
    • Pre-Filled Needle Free Injectors
    • Fill-Able Needle Free Injectors
  • Auto-Injectors
    • Pre-Filled Auto-Injector
    • Fill-Able Auto-Injector
  • Wearable Injectors
    • Wearable Patch Injectors
    • Off-body Worn Injectors
  • Insulin Pens
    • Reusable Insulin Pens
    • Disposable Insulin Pens
    • Smart Insulin Pens
  • Implantable Drug Delivery
    • Contraceptive Implants
    • Intravitreal Implants
    • Buprenorphine Subdermal Implant
    • Implantable Infusion Pumps
  • Transdermal Patches
    • Drug in Adhesive Patches
    • Matrix Patches
    • Microneedle Patches
    • Reservoir Patches

By Usage:

  • Disposable Devices
  • Reusable Devices

By Route of Administration:

  • Transdermal
  • Subcutaneous
  • Intramuscular
  • Implantable

By Sales Channel:

  • Hospitals
  • Specialty Clinics
  • Retail Pharmacy Chains
  • Drug Stores
  • Online Sales Channel

By Application:

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Cancer
  • Hormonal Therapy
  • Ophthalmology
  • Others

By Geographic Coverage:

  • North America
    • United States
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Europe
    • Germany
    • Italy
    • France
    • U.K.
    • Spain
    • Benelux
    • Nordic Countries
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltics
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkey
    • South Africa
    • Other African Union
    • Israel
    • Rest of Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Drug Delivery Devices Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
    • 2.2.4. Supply
    • 2.2.5. Demand
  • 2.3. Forecast Factors - Relevance and Impact
  • 2.4. Economic Overview
    • 2.4.1. World Economic Projections

3. Value Added Insights

  • 3.1. Promotional Strategies by Key Players
  • 3.2. New Product Approvals/Launch
  • 3.3. Parent Market Analysis, 2023
  • 3.4. Value Chain Analysis
  • 3.5. Porter's Five Forces Analysis
  • 3.6. COVID-19 Impact Analysis
  • 3.7. PESTLE Analysis

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Drug Delivery Devices Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Drug Delivery Devices Market Outlook, 2018 - 2033

  • 5.1. Global Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 5.1.1. Key Highlights
      • 5.1.1.1. Self-Injector
        • 5.1.1.1.1. Single Chamber Self Injector
        • 5.1.1.1.2. Dual Chamber Self Injector
      • 5.1.1.2. Needle-Free Injectors
        • 5.1.1.2.1. Pre-Filled Needle Free Injectors
        • 5.1.1.2.2. Fill-Able Needle Free Injectors
      • 5.1.1.3. Auto-Injectors
        • 5.1.1.3.1. Pre-Filled Auto Injector
        • 5.1.1.3.2. Fill-Able Auto Injector
      • 5.1.1.4. Wearable Injectors
        • 5.1.1.4.1. Wearable Patch Injectors
        • 5.1.1.4.2. Off-body Worn Injectors
      • 5.1.1.5. Insulin Pens
        • 5.1.1.5.1. Reusable Insulin Pens
        • 5.1.1.5.2. Disposable Insulin Pens
        • 5.1.1.5.3. Smart Insulin Pens
      • 5.1.1.6. Implantable Drug Delivery
        • 5.1.1.6.1. Contraceptive Implants
        • 5.1.1.6.2. Intravitreal Implants
        • 5.1.1.6.3. Buprenorphine Subdermal Implant
        • 5.1.1.6.4. Implantable Infusion Pumps
      • 5.1.1.7. Transdermal Patches
        • 5.1.1.7.1. Drug in Adhesive Patches
        • 5.1.1.7.2. Matrix Patches
        • 5.1.1.7.3. Microneedle Patches
        • 5.1.1.7.4. Reservoir Patches
  • 5.2. Global Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn)
    • 5.2.1. Key Highlights
      • 5.2.1.1. Disposable Devices
      • 5.2.1.2. Reusable Devices
  • 5.3. Global Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2033
    • 5.3.1. Key Highlights
      • 5.3.1.1. Transdermal
      • 5.3.1.2. Subcutaneous
      • 5.3.1.3. Intramuscular
      • 5.3.1.4. Implantable
  • 5.4. Global Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2033
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Specialty Clinics
      • 5.4.1.3. Retail Pharmacy Chains
      • 5.4.1.4. Drug Stores
      • 5.4.1.5. Online Sales Channel
  • 5.5. Global Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
    • 5.5.1. Key Highlights
      • 5.5.1.1. Diabetes
      • 5.5.1.2. Anaphylaxis
      • 5.5.1.3. Rheumatoid Arthritis
      • 5.5.1.4. Cancer
      • 5.5.1.5. Hormonal Therapy
      • 5.5.1.6. Ophthalmology
      • 5.5.1.7. Others
  • 5.6. Global Drug Delivery Devices Market Outlook, by Region, Value (US$ Bn) , 2018 - 2033
    • 5.6.1. Key Highlights
      • 5.6.1.1. North America
      • 5.6.1.2. Latin America
      • 5.6.1.3. Europe
      • 5.6.1.4. Asia Pacific
      • 5.6.1.5. Middle East & Africa

6. North America Drug Delivery Devices Market Outlook, 2018 - 2033

  • 6.1. North America Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 6.1.1. Key Highlights
      • 6.1.1.1. Self-Injector
        • 6.1.1.1.1. Single Chamber Self Injector
        • 6.1.1.1.2. Dual Chamber Self Injector
      • 6.1.1.2. Needle Free Injectors
        • 6.1.1.2.1. Pre-Filled Needle Free Injectors
        • 6.1.1.2.2. Fill-Able Needle Free Injectors
      • 6.1.1.3. Auto Injectors
        • 6.1.1.3.1. Pre-Filled Auto Injector
        • 6.1.1.3.2. Fill-Able Auto Injector
      • 6.1.1.4. Wearable Injectors
        • 6.1.1.4.1. Wearable Patch Injectors
        • 6.1.1.4.2. Off-body Worn Injectors
      • 6.1.1.5. Insulin Pens
        • 6.1.1.5.1. Reusable Insulin Pens
        • 6.1.1.5.2. Disposable Insulin Pens
        • 6.1.1.5.3. Smart Insulin Pens
      • 6.1.1.6. Implantable Drug Delivery
        • 6.1.1.6.1. Contraceptive Implants
        • 6.1.1.6.2. Intravitreal Implants
        • 6.1.1.6.3. Buprenorphine Subdermal Implant
        • 6.1.1.6.4. Implantable Infusion Pumps
      • 6.1.1.7. Transdermal Patches
        • 6.1.1.7.1. Drug in Adhesive Patches
        • 6.1.1.7.2. Matrix Patches
        • 6.1.1.7.3. Microneedle Patches
      • 6.1.1.8. Reservoir Patches
  • 6.2. North America Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn), 2018 - 2033
    • 6.2.1. Key Highlights
      • 6.2.1.1. Disposable Devices
      • 6.2.1.2. Reusable Devices
  • 6.3. North America Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2033
    • 6.3.1. Key Highlights
      • 6.3.1.1. Transdermal
      • 6.3.1.2. Subcutaneous
      • 6.3.1.3. Intramuscular
      • 6.3.1.4. Implantable
  • 6.4. North America Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2033
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Specialty Clinics
      • 6.4.1.3. Retail Pharmacy Chains
      • 6.4.1.4. Drug Stores
      • 6.4.1.5. Online Sales Channel
  • 6.5. North America Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2033
    • 6.5.1. Key Highlights
      • 6.5.1.1. Diabetes
      • 6.5.1.2. Anaphylaxis
      • 6.5.1.3. Rheumatoid Arthritis
      • 6.5.1.4. Cancer
      • 6.5.1.5. Hormonal Therapy
      • 6.5.1.6. Ophthalmology
      • 6.5.1.7. Others
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis
  • 6.6. North America Drug Delivery Devices Market Share Analysis (%) Outlook, by Country, 2023 & 2033
    • 6.6.1. Key Highlights
      • 6.6.1.1. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 6.6.1.2. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 6.6.1.3. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 6.6.1.4. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 6.6.1.5. U.S. Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 6.6.1.6. Canada Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 6.6.1.7. Canada Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 6.6.1.8. Canada Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 6.6.1.9. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 6.6.1.10. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 6.6.1.11. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 6.6.1.12. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 6.6.1.13. Mexico Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
    • 6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Drug Delivery Devices Market Outlook, 2018 - 2033

  • 7.1. Latin America Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 7.1.1. Key Highlights
      • 7.1.1.1. Self-Injector
        • 7.1.1.1.1. Single Chamber Self Injector
        • 7.1.1.1.2. Dual Chamber Self Injector
      • 7.1.1.2. Needle Free Injectors
        • 7.1.1.2.1. Pre-Filled Needle Free Injectors
        • 7.1.1.2.2. Fill-Able Needle Free Injectors
      • 7.1.1.3. Auto Injectors
        • 7.1.1.3.1. Pre-Filled Auto Injector
        • 7.1.1.3.2. Fill-Able Auto Injector
      • 7.1.1.4. Wearable Injectors
        • 7.1.1.4.1. Wearable Patch Injectors
        • 7.1.1.4.2. Off-body Worn Injectors
      • 7.1.1.5. Insulin Pens
        • 7.1.1.5.1. Reusable Insulin Pens
        • 7.1.1.5.2. Disposable Insulin Pens
        • 7.1.1.5.3. Smart Insulin Pens
      • 7.1.1.6. Implantable Drug Delivery
        • 7.1.1.6.1. Contraceptive Implants
        • 7.1.1.6.2. Intravitreal Implants
        • 7.1.1.6.3. Buprenorphine Subdermal Implant
        • 7.1.1.6.4. Implantable Infusion Pumps
      • 7.1.1.7. Transdermal Patches
        • 7.1.1.7.1. Drug in Adhesive Patches
        • 7.1.1.7.2. Matrix Patches
        • 7.1.1.7.3. Microneedle Patches
      • 7.1.1.8. Reservoir Patches
  • 7.2. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 7.2.1.1. Disposable Devices
      • 7.2.1.2. Reusable Devices
  • 7.3. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
    • 7.3.1. Key Highlights
      • 7.3.1.1. Transdermal
      • 7.3.1.2. Subcutaneous
      • 7.3.1.3. Intramuscular
      • 7.3.1.4. Implantable
  • 7.4. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Specialty Clinics
      • 7.4.1.3. Retail Pharmacy Chains
      • 7.4.1.4. Drug Stores
      • 7.4.1.5. Online Sales Channel
  • 7.5. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
    • 7.5.1. Key Highlights
      • 7.5.1.1. Diabetes
      • 7.5.1.2. Anaphylaxis
      • 7.5.1.3. Rheumatoid Arthritis
      • 7.5.1.4. Cancer
      • 7.5.1.5. Hormonal Therapy
      • 7.5.1.6. Ophthalmology
      • 7.5.1.7. Others
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis
  • 7.6. Latin America Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 7.6.1. Key Highlights
      • 7.6.1.1. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 7.6.1.2. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 7.6.1.3. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 7.6.1.4. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 7.6.1.5. Brazil Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 7.6.1.6. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 7.6.1.7. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 7.6.1.8. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 7.6.1.9. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 7.6.1.10. Chile Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
    • 7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Europe Drug Delivery Devices Market Outlook, 2018 - 2033

  • 8.1. Europe Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 8.1.1. Key Highlights
      • 8.1.1.1. Self-Injector
        • 8.1.1.1.1. Single Chamber Self Injector
        • 8.1.1.1.2. Dual Chamber Self Injector
      • 8.1.1.2. Needle Free Injectors
        • 8.1.1.2.1. Pre-Filled Needle Free Injectors
        • 8.1.1.2.2. Fill-Able Needle Free Injectors
      • 8.1.1.3. Auto Injectors
        • 8.1.1.3.1. Pre-Filled Auto Injector
        • 8.1.1.3.2. Fill-Able Auto Injector
      • 8.1.1.4. Wearable Injectors
        • 8.1.1.4.1. Wearable Patch Injectors
        • 8.1.1.4.2. Off-body Worn Injectors
      • 8.1.1.5. Insulin Pens
        • 8.1.1.5.1. Reusable Insulin Pens
        • 8.1.1.5.2. Disposable Insulin Pens
        • 8.1.1.5.3. Smart Insulin Pens
      • 8.1.1.6. Implantable Drug Delivery
        • 8.1.1.6.1. Contraceptive Implants
        • 8.1.1.6.2. Intravitreal Implants
        • 8.1.1.6.3. Buprenorphine Subdermal Implant
        • 8.1.1.6.4. Implantable Infusion Pumps
      • 8.1.1.7. Transdermal Patches
        • 8.1.1.7.1. Drug in Adhesive Patches
        • 8.1.1.7.2. Matrix Patches
        • 8.1.1.7.3. Microneedle Patches
      • 8.1.1.8. Reservoir Patches
  • 8.2. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
    • 8.2.1. Key Highlights
      • 8.2.1.1. Disposable Devices
      • 8.2.1.2. Reusable Devices
  • 8.3. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
    • 8.3.1. Key Highlights
      • 8.3.1.1. Transdermal
      • 8.3.1.2. Subcutaneous
      • 8.3.1.3. Intramuscular
      • 8.3.1.4. Implantable
  • 8.4. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Specialty Clinics
      • 8.4.1.3. Retail Pharmacy Chains
      • 8.4.1.4. Drug Stores
      • 8.4.1.5. Online Sales Channel
  • 8.5. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
    • 8.5.1. Key Highlights
      • 8.5.1.1. Diabetes
      • 8.5.1.2. Anaphylaxis
      • 8.5.1.3. Rheumatoid Arthritis
      • 8.5.1.4. Cancer
      • 8.5.1.5. Hormonal Therapy
      • 8.5.1.6. Ophthalmology
      • 8.5.1.7. Others
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis
  • 8.6. Europe Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 8.6.1. Key Highlights
      • 8.6.1.1. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.2. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.3. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.4. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.5. Germany Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.6. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.7. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.8. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.9. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.10. Italy Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.11. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.12. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.13. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.14. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.15. France Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.16. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.17. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.18. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.19. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.20. U.K. Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.21. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.22. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.23. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.24. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.25. Spain Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.26. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.27. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.28. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.29. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.30. Benelux Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.31. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.32. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.33. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.34. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.35. Nordic Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.36. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.37. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.38. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.39. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.40. Russia Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.41. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.42. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.43. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.44. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.45. Poland Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.46. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.47. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.48. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.49. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.50. Hungary Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 8.6.1.51. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 8.6.1.52. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 8.6.1.53. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 8.6.1.54. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 8.6.1.55. Balkan & Baltics Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033

9. Asia Pacific Drug Delivery Devices Market Outlook, 2018 - 2033

  • 9.1. Asia Pacific Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 9.1.1. Key Highlights
      • 9.1.1.1. Self-Injector
        • 9.1.1.1.1. Single Chamber Self Injector
        • 9.1.1.1.2. Dual Chamber Self Injector
      • 9.1.1.2. Needle Free Injectors
        • 9.1.1.2.1. Pre-Filled Needle Free Injectors
        • 9.1.1.2.2. Fill-Able Needle Free Injectors
      • 9.1.1.3. Auto Injectors
        • 9.1.1.3.1. Pre-Filled Auto Injector
        • 9.1.1.3.2. Fill-Able Auto Injector
      • 9.1.1.4. Wearable Injectors
        • 9.1.1.4.1. Wearable Patch Injectors
        • 9.1.1.4.2. Off-body Worn Injectors
      • 9.1.1.5. Insulin Pens
        • 9.1.1.5.1. Reusable Insulin Pens
        • 9.1.1.5.2. Disposable Insulin Pens
        • 9.1.1.5.3. Smart Insulin Pens
      • 9.1.1.6. Implantable Drug Delivery
        • 9.1.1.6.1. Contraceptive Implants
        • 9.1.1.6.2. Intravitreal Implants
        • 9.1.1.6.3. Buprenorphine Subdermal Implant
        • 9.1.1.6.4. Implantable Infusion Pumps
      • 9.1.1.7. Transdermal Patches
        • 9.1.1.7.1. Drug in Adhesive Patches
        • 9.1.1.7.2. Matrix Patches
        • 9.1.1.7.3. Microneedle Patches
      • 9.1.1.8. Reservoir Patches
  • 9.2. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
    • 9.2.1. Key Highlights
      • 9.2.1.1. Disposable Devices
      • 9.2.1.2. Reusable Devices
  • 9.3. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
    • 9.3.1. Key Highlights
      • 9.3.1.1. Transdermal
      • 9.3.1.2. Subcutaneous
      • 9.3.1.3. Intramuscular
      • 9.3.1.4. Implantable
  • 9.4. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
    • 9.4.1. Key Highlights
      • 9.4.1.1. Hospitals
      • 9.4.1.2. Specialty Clinics
      • 9.4.1.3. Retail Pharmacy Chains
      • 9.4.1.4. Drug Stores
      • 9.4.1.5. Online Sales Channel
  • 9.5. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
    • 9.5.1. Key Highlights
      • 9.5.1.1. Diabetes
      • 9.5.1.2. Anaphylaxis
      • 9.5.1.3. Rheumatoid Arthritis
      • 9.5.1.4. Cancer
      • 9.5.1.5. Hormonal Therapy
      • 9.5.1.6. Ophthalmology
      • 9.5.1.7. Others
    • 9.5.2. BPS Analysis/Market Attractiveness Analysis
  • 9.6. Asia Pacific Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 9.6.1. Key Highlights
      • 9.6.1.1. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.2. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.3. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.4. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.5. China Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 9.6.1.6. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.7. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.8. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.9. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.10. Japan Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 9.6.1.11. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.12. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.13. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.14. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.15. South Korea Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 9.6.1.16. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.17. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.18. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.19. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.20. India Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 9.6.1.21. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.22. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.23. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.24. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.25. Indonesia Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 9.6.1.26. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.27. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.28. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.29. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.30. Malaysia Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 9.6.1.31. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.32. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.33. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.34. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.35. Philippines Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 9.6.1.36. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.37. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.38. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.39. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.40. Thailand Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 9.6.1.41. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.42. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.43. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.44. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.45. Vietnam Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 9.6.1.46. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 9.6.1.47. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 9.6.1.48. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 9.6.1.49. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 9.6.1.50. Australia & New Zealand Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
    • 9.6.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Drug Delivery Devices Market Outlook, 2018 - 2033

  • 10.1. Middle East & Africa Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 10.1.1. Key Highlights
      • 10.1.1.1. Self-Injector
        • 10.1.1.1.1. Single Chamber Self Injector
        • 10.1.1.1.2. Dual Chamber Self Injector
      • 10.1.1.2. Needle Free Injectors
        • 10.1.1.2.1. Pre-Filled Needle Free Injectors
        • 10.1.1.2.2. Fill-Able Needle Free Injectors
      • 10.1.1.3. Auto Injectors
        • 10.1.1.3.1. Pre-Filled Auto Injector
        • 10.1.1.3.2. Fill-Able Auto Injector
      • 10.1.1.4. Wearable Injectors
        • 10.1.1.4.1. Wearable Patch Injectors
        • 10.1.1.4.2. Off-body Worn Injectors
      • 10.1.1.5. Insulin Pens
        • 10.1.1.5.1. Reusable Insulin Pens
        • 10.1.1.5.2. Disposable Insulin Pens
        • 10.1.1.5.3. Smart Insulin Pens
      • 10.1.1.6. Implantable Drug Delivery
        • 10.1.1.6.1. Contraceptive Implants
        • 10.1.1.6.2. Intravitreal Implants
        • 10.1.1.6.3. Buprenorphine Subdermal Implant
        • 10.1.1.6.4. Implantable Infusion Pumps
      • 10.1.1.7. Transdermal Patches
        • 10.1.1.7.1. Drug in Adhesive Patches
        • 10.1.1.7.2. Matrix Patches
        • 10.1.1.7.3. Microneedle Patches
      • 10.1.1.8. Reservoir Patches
  • 10.2. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
    • 10.2.1. Key Highlights
      • 10.2.1.1. Disposable Devices
      • 10.2.1.2. Reusable Devices
  • 10.3. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
    • 10.3.1. Key Highlights
      • 10.3.1.1. Transdermal
      • 10.3.1.2. Subcutaneous
      • 10.3.1.3. Intramuscular
      • 10.3.1.4. Implantable
  • 10.4. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
    • 10.4.1. Key Highlights
      • 10.4.1.1. Hospitals
      • 10.4.1.2. Specialty Clinics
      • 10.4.1.3. Retail Pharmacy Chains
      • 10.4.1.4. Drug Stores
      • 10.4.1.5. Online Sales Channel
  • 10.5. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
    • 10.5.1. Key Highlights
      • 10.5.1.1. Diabetes
      • 10.5.1.2. Anaphylaxis
      • 10.5.1.3. Rheumatoid Arthritis
      • 10.5.1.4. Cancer
      • 10.5.1.5. Hormonal Therapy
      • 10.5.1.6. Ophthalmology
      • 10.5.1.7. Others
    • 10.5.2. BPS Analysis/Market Attractiveness Analysis
  • 10.6. Middle East & Africa Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
    • 10.6.1. Key Highlights
      • 10.6.1.1. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 10.6.1.2. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 10.6.1.3. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 10.6.1.4. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 10.6.1.5. Kingdom of Saudi Arabia Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 10.6.1.6. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 10.6.1.7. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 10.6.1.8. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 10.6.1.9. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 10.6.1.10. Other GCC Countries Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 10.6.1.11. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 10.6.1.12. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 10.6.1.13. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 10.6.1.14. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 10.6.1.15. Turkey Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 10.6.1.16. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 10.6.1.17. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 10.6.1.18. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 10.6.1.19. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 10.6.1.20. South Africa Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 10.6.1.21. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Product, 2023 & 2033
      • 10.6.1.22. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Usage, 2023 & 2033
      • 10.6.1.23. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
      • 10.6.1.24. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
      • 10.6.1.25. Israel Drug Delivery Devices Market Share Analysis (%) Outlook, by Application, 2023 & 2033
      • 10.6.1.26. Share Analysis (%) Outlook, by Application, 2023 & 2033
    • 10.6.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. Company Market Share Analysis, 2023
  • 11.2. Competitive Dashboard
  • 11.3. Company Profiles
    • 11.3.1. Eli Lilly and Company
      • 11.3.1.1. Company Overview
      • 11.3.1.2. Product Portfolio
      • 11.3.1.3. Financial Overview
      • 11.3.1.4. Business Strategies and Development
    • 11.3.2. Becton Dickinson And Co.
      • 11.3.2.1. Company Overview
      • 11.3.2.2. Product Portfolio
      • 11.3.2.3. Financial Overview
      • 11.3.2.4. Business Strategies and Development
    • 11.3.3. Novo Nordisk
      • 11.3.3.1. Company Overview
      • 11.3.3.2. Product Portfolio
      • 11.3.3.3. Financial Overview
      • 11.3.3.4. Business Strategies and Development
    • 11.3.4. Sanofi
      • 11.3.4.1. Company Overview
      • 11.3.4.2. Product Portfolio
      • 11.3.4.3. Financial Overview
      • 11.3.4.4. Business Strategies and Development
    • 11.3.5. Johnson & Johnson
      • 11.3.5.1. Company Overview
      • 11.3.5.2. Product Portfolio
      • 11.3.5.3. Financial Overview
      • 11.3.5.4. Business Strategies and Development
    • 11.3.6. Roche
      • 11.3.6.1. Company Overview
      • 11.3.6.2. Product Portfolio
      • 11.3.6.3. Financial Overview
      • 11.3.6.4. Business Strategies and Development
    • 11.3.7. Pfizer
      • 11.3.7.1. Company Overview
      • 11.3.7.2. Product Portfolio
      • 11.3.7.3. Financial Overview
      • 11.3.7.4. Business Strategies and Development
    • 11.3.8. AbbVie
      • 11.3.8.1. Company Overview
      • 11.3.8.2. Product Portfolio
      • 11.3.8.3. Financial Overview
      • 11.3.8.4. Business Strategies and Development
    • 11.3.9. Mylan N.V. (Viatris)
      • 11.3.9.1. Company Overview
      • 11.3.9.2. Product Portfolio
      • 11.3.9.3. Financial Overview
      • 11.3.9.4. Business Strategies and Development
    • 11.3.10. Insulet corporation
      • 11.3.10.1. Company Overview
      • 11.3.10.2. Product Portfolio
      • 11.3.10.3. Financial Overview
      • 11.3.10.4. Business Strategies and Development
    • 11.3.11. Medtronic plc
      • 11.3.11.1. Company Overview
      • 11.3.11.2. Product Portfolio
      • 11.3.11.3. Financial Overview
      • 11.3.11.4. Business Strategies and Development
    • 11.3.12. Others

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!